Reversal of neuromuscular blockade

Reversal of neuromuscular blockade refers to the pharmacologic antagonism of iatrogenic, drug-induced skeletal muscle paralysis following the administration of neuromuscular blocking agents, typically in perioperative or critical care settings

Reversal of neuromuscular blockade refers to the pharmacologic antagonism of iatrogenic, drug-induced skeletal muscle paralysis following the administration of neuromuscular blocking agents, typically in perioperative or critical care settings

This intervention targets the peripheral neuromuscular system, specifically reversing the interruption of synaptic transmission at postsynaptic nicotinic acetylcholine receptors on the motor endplate

This intervention targets the peripheral neuromuscular system, specifically reversing the interruption of synaptic transmission at postsynaptic nicotinic acetylcholine receptors on the motor endplate

Clinically, incomplete resolution or residual blockade impairs protective airway reflexes, respiratory mechanics, and voluntary motor function, elevating the risk for hypoxemia, upper airway obstruction, and postoperative pulmonary complications

Clinically, incomplete resolution or residual blockade impairs protective airway reflexes, respiratory mechanics, and voluntary motor function, elevating the risk for hypoxemia, upper airway obstruction, and postoperative pulmonary complications

Restoring normal neuromuscular transmission—quantified objectively by recovery of the train-of-four ratio to 0.9 or greater—is essential for safe emergence from general anesthesia, successful tracheal extubation, and the return of spontaneous ventilation

Restoring normal neuromuscular transmission—quantified objectively by recovery of the train-of-four ratio to 0.9 or greater—is essential for safe emergence from general anesthesia, successful tracheal extubation, and the return of spontaneous ventilation